Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Harvard Bioscience Inc

Current price
3.3 USD +0.2 USD (+6.45%)
Last closed 3.13 USD
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 135 934 656 USD
Yield for 12 month -33.87 %
21.11.2021 - 28.11.2021

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts. Address: 84 October Hill Road, Holliston, MA, United States, 01746

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

6.92 USD

P/E ratio

Dividend Yield

Current Year

+112 250 000 USD

Last Year

+113 335 000 USD

Current Quarter

+24 512 000 USD

Last Quarter

+28 153 000 USD

Current Year

+60 866 000 USD

Last Year

+60 819 000 USD

Current Quarter

+13 439 000 USD

Last Quarter

+14 938 000 USD

Key Figures HBIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 5 525 000 USD
Operating Margin TTM -9.3 %
PE Ratio
Return On Assets TTM -0.69 %
PEG Ratio 2.89
Return On Equity TTM -12.2 %
Wall Street Target Price 6.92 USD
Revenue TTM 106 787 000 USD
Book Value 1.59 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -18.2 %
Dividend Yield
Gross Profit TTM 62 290 000 USD
Earnings per share -0.2 USD
Diluted Eps TTM -0.2 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY -80.3 %
Profit Margin -8.18 %

Dividend Analytics HBIO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History HBIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1319:1000
Payout Ratio
Last Split Date 04.11.2013
Dividend Date

Stock Valuation HBIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 14.9254
Enterprise Value Revenue 1.9869
Price Sales TTM 1.6401
Enterprise Value EBITDA 27.7643
Price Book MRQ 2.5254

Financials HBIO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators HBIO

For 52 weeks

2.7 USD 5.56 USD
50 Day MA 3.1 USD
Shares Short Prior Month 386 199
200 Day MA 4.09 USD
Short Ratio 2.42
Shares Short 534 364
Short Percent 1.32 %

Dynamics of changes in the value of assets



57.21 SEK Bjorn Borg AB -0.02 (-0.44%)
Detailed analytics


4 075.00 JPY Asakuma Co.Ltd +0.76 (+3.03%)
Detailed analytics


1 440.00 JPY Iwatsu Electric Co Ltd +0.02 (+0.21%)
Detailed analytics


0.074 EUR Maxi-Cash Financial Services Corporation Ltd +0 (+0%)
Detailed analytics


4.45 EUR PHOTOCURE ASA NK-50 0 (0%)
Detailed analytics